Immunohistochemical study of proteoglycans in D-galactosamine-induced acute liver injury in rats

Journal of Gastroenterology

Volumn 31, Issue 1, 1996, Pages 46-54

  Sasaki, Shunsuke ^a   Koide, Norio ^a   Shinji, Toshiyuki ^a   Tsuji, Takao ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Chondroitin chondroitin sulfate; D galactosamine hydrochloride; Dermatan sulfate; Extracellular matrix; Heparan sulfate

Indexed keywords

CHONDROITIN; CHONDROITIN SULFATE; CYCLINE; DERMATAN SULFATE; GALACTOSAMINE; HEPARAN SULFATE; PROTEOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; ITO CELL; LIVER CELL; LIVER INJURY; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALANINE TRANSAMINASE; ANIMALS; DERMATAN SULFATE; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; GALACTOSAMINE; HEPARITIN SULFATE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER DISEASES; MALE; MICROSCOPY, ELECTRON; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEOGLYCANS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030025846     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01211186     Document Type: Article

References (35)

1. Schuppan D. Structure of the extracellular matrix in normal and fibrotic liver: Collagens and glycoproteins. Semin Liver Dis 1990,10:1-10.
2. Martinez-Hernandez A, Amenta PS. Morphology, localization and origin of the hepatic extracellular matrix. In: Zern MA, Reid LM (eds) Extracellular matrix: Chemistry, biology, and pathobiology with emphasis on the liver New York: Marcel Dekker, 1993;255-327.
3. Koide N, Sakaguchi K, Koide Y, et al. Formation of multicellular spheroids composed of adult rat hepatocytes in dishes with positively charged surfaces and under other nonadherent environments. Exp Cell Res 1990;186.227-235.
4. Murata K, Ochiai Y, Akashio K. Polydispersity of acidic glycosaminoglycan components in human liver and the changes at different stages in liver cirrhosis. Gastroenterol 1985;89:1248-1257.
5. Jezequel AM, Ballardini G, Mancini R, et al. Modulation of extracellular matrix components during dimethylnitrososamine-induced cirrhosis. J Hepatology 1990;11:206-214.
6. Kure S, Yoshie O A syngeneic monoclonal antibody to murine meth-A sarcoma (HepSS-1) recognizes heparan sulfate glycosaminoglycan (HS-GAG): Cell density and transformation-dependent alteration in cell surface HS-GAG defined by HepSS-1. J Immunol 1986;137:3900-3908.
7. Sobue M, Nakashima N, Fukatsu T, et al. Production and characterization of monoclonal antibody to dermatan sulfate proteoglycan. J Histochem Cytochem 1988;36:479-485.
8. Poole AR, Webber C, Pidoux I, et al Localization of a dermatan sulfate proteoglycan (DS-PGII) in cartilage and the presence of an immunologically related species in other tissues. J Histochem Cytochem 1986;34:619-625.
9. Couchman JR, Caterson B, Christner JE, Baker JR. Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissues. Nature 1984;307:650-652.
10. Callea F, Mebis J, Desmet VJ. Myofibroblasts in focal nodular hyperplasia of the liver. Virchows Arch [A] 1982;396:155-166.
11. Geerts A, Lazou JM, Bleser de P, et al. Tissue distribution, quantitation, and proliferation kinetics of fat-storing cells in carbon tetrachloride-injured rat liver. Hepatology 1991;13: 1193-1202.
12. Matsumoto T, Komori R, Magara T, et al. A study on the normal structure of the human liver, with special reference to its angioarchitecture (in Japanese with English abstract). Kanzo (Acta Hepatol Jpn) 1979;20:223-247.
13. Prelich G, Kostura M, Marshak DR, et al. The cell-cycle regulated proliferating cell nuclear antigen is required for SV40 DNA replication m vitro. Nature 1987,325:471-475.
14. Decker K, Keppler D. Galactosamine-induced liver injury. In: Popper HP, Schaffner F (eds) Progress in liver diseases. Vol 4. New York: Grune and Stratton, 1972;183-199.
15. Zimmerman HJ, Maddrey WC. Toxic and drug-induced hepatitis. In: Schiff L, Schiff ER (eds) Diseases of the liver. 6th Ed. Philadelphia: J.B. Lippincott, 1987:591-667.
16. Gressner AM, Lotfi S, Gressner G, et al. Identification and partial characterization of a hepatocyte-derived factor promoting proliferation of cultured fat-storing cells (parasmusoidal lipocytes). Hepatology 1992;16:1250-1266.
17. Kjellén L, Lindahl U Proteoglycans: Structures and interactions. Annu Rev Biochem 1991;60:443-475.
18. Rouslahti E. Structure and biology of proteoglycans. Ann Rev Cell Biol 1988,4:229-255.
19. Soroka CL, Farquhar MC. Characterization of a novel heparan sulfate proteoglycan found in the extracellular matrix of liver sinusoids and basement membranes. J Cell Biol 1991;113.1231-1241.
20. Noonan DM, Fulle A, Valente P, et al. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminine A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J Biol Chem 1991;266:22939-22947.
21. Bernfield M, Kokenyrsi R, Kato M, et al Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 1992;8.365-393.
22. Karthikeyan L, Maurel P, Rauch U, et al. Cloning of a major heparan sulfate proteoglycan from brain and identification as the rat form of glypican. Biochem Biophys Res Commun 1992; 188:395-401.
23. David G, B van der Schueren, Marynen P, Cassiman JJ, et al. Molecular cloning of amphyglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J Cell Biol 1992;118:961-969.
24. Bourdon MA, Oldberg Å, Pierschbacher M, et al Molecular cloning and sequence analysis of a chondroitin sulfate proteoalycan cDNA. Proc Natl Acad Sci USA 1985;82:1321-1325
25. Meyer DH, Krull N, Dreher KL, et al. Biglycan and decorin gene expression in normal and fibrotic rat liver: Cellular localization and regulatory factors. Hepatology 1992;16:204-216.
26. Gressner AM, Pfeiffer T. Preventive effects of acute inflammation on liver cell necrosis and inhibition of heparan sulfate synthesis in hepatocytes. J Clin Chem Clin Biochem 1986;24: 821-829.
27. Preston SF, Regula PR, Sager CB, et al. Glycosaminoglycan synthesis is depressed during mitosis and elevated during early G1. J Cell Biol 1985;101:1086-1093
28. Doege KJ, Sasaki M, Kimura T, et al. Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. J Biol Chem 1991; 266:894-902.
29. Yamagata M, Suzuki S, Akiyama SK, et al. Chondroitin sulfate proteoglycan (PG-M-like proteoglycan) is involved in the binding of hyaluronic acid to cellular fibronectin. J Biol Chem 1986; 261:13526-13535
30. Maurel P, Rauch U, Flad M, et al. Phosphacan, a chondroitin sulfate proteoglycan of brain that interacts with neurons and neural cell-adhesion molecules, is an extracellular variant of a receptor-type protein tyrosine phosphatase. Proc Natl Acad Sci USA 1994;91:2512-2516.
31. Nishiyama A, Dahlin KJ, Prince JT, et al. The primary structure of NG2, a novel membrane-spanning proteoglycan. J Cell Biol 1991;114:359-371.
32. Lohmander LS, Arnljots K, Yanagisita M. Structure and synthesis of intracellular proteoglycan in HL-60 human leukemic promyelocytes. J Biol Chem 1990;265:5802-5808.
33. Faassen AE, Mooradian DL, Tranquillo RT, et al. Cell surface CD44-related chondroitin sulfate proteoglycan is required for transforming growth factor-β-stimulated mouse melanoma cell motility and invasive behavior on type I collagen. J Cell Sci 1993;105:501-511.
34. Arenson DM, Friedman SL, Bissell DM. Formation of extracellular matrix in normal rat liver: Lipocytes as a major source of proteoglycan. Gastroenterology 1988,95:441-447.
35. Gressner AM, Bachem MG. Cellular sources of noncollagenous matrix proteins: Role of fat-storing cells in fibrogenesis. Semin Liv Dis 1990;10:30-46.